### Eversense E3 Implantable Continuous Glucose Monitor (CGM) Overview The Eversense E3 is an innovative implantable continuous glucose monitor (CGM) that offers several benefits and unique features for people with diabetes. Here are the key points: - **Longer Wear Time**: The Eversense E3 can be worn for up to 6 months, reducing the need for frequent replacements compared to traditional CGMs that typically last 7 to 10 days. - **Implantable Sensor**: Unlike traditional CGMs that are worn externally, the Eversense E3 sensor is implanted under the skin. This makes it less obtrusive and more convenient for long-term use. - **Transmitter**: To get glucose readings, users wear a small transmitter on the skin over the sensor. The transmitter sends data to a smartphone app every 5 minutes. It can be removed and reattached as needed, such as during showers or sports activities. - **Vibration Alerts**: The transmitter can vibrate to alert users of high or low glucose levels, providing a discreet way to stay informed without audible alarms. - **Smartphone Connectivity**: The Eversense E3 does not require a separate receiver. Instead, it connects directly to a compatible smartphone, displaying glucose data and alerts through a dedicated app. - **Predictive Alerts**: The system can predict glucose highs and lows 10 to 30 minutes in advance, helping users take proactive measures to manage their diabetes. - **Data Sharing**: Users can share their glucose data with healthcare providers or loved ones through the app, facilitating better diabetes management and support. - **Accuracy**: Clinical trials have shown that the Eversense E3 has a high level of accuracy, with a Mean Absolute Relative Difference (MARD) of 8.5%, making it one of the most accurate CGMs available. - **Insurance Coverage**: The Eversense system is covered by major insurers and Medicare, making it accessible to a wider range of patients. Overall, the Eversense E3 offers a convenient, accurate, and long-lasting solution for continuous glucose monitoring, improving the quality of life for people with diabetes.